Linagliptin Improves Glycemic Control in Type 2 Diabetes Patients Inadequately Controlled by Metformin and Sulfonylurea without Weight Gain or Hypoglycemia

被引：0

|

作者：

Owens, David R.

Swallow, Ros

Jones, Peter

Dugi, Klaus A.

Woerle, Hans-Juergen

机构：

来源：

DIABETES | 2010年 / 59卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A149 / A149

页数：1

相关论文

共 50 条

[31] Canagliflozin (CANA), a Sodium Glucose Co-Transporter 2 Inhibitor, Improves Glycemic Control and Reduces Body Weight in Subjects With Type 2 Diabetes (T2D) Inadequately Controlled With Metformin (MET) and Sulfonylurea (SU)
Wilding, John
Mathieu, Chantal
Vercruysse, Frank
Usiskin, Keith
Deng, Ling
Canovatchel, William
DIABETES, 2012, 61 : A262 - A262
[32] Efficacy of dapagliflozin plus saxagliptin vs insulin glargine at 52 weeks in patients with type 2 diabetes inadequately controlled by metformin with or without sulfonylurea
Vilsboll, T.
Ekholm, E.
Johnsson, E.
Garcia-Sanchez, R.
Dronamraju, N.
Jabbour, S. A.
Lind, M.
DIABETOLOGIA, 2018, 61 : S380 - S380
[33] Efficacy and safety of lixisenatide in Japanese patients with type 2 diabetes mellitus inadequately controlled by sulfonylurea with or without metformin: Subanalysis of GetGoal-S
Onishi, Yukiko
Niemoeller, Elisabeth
Ikeda, Yukio
Takagi, Hiroki
Yabe, Daisuke
Seino, Yutaka
JOURNAL OF DIABETES INVESTIGATION, 2015, 6 (02) : 201 - 209
[34] Troglitazone improves glycemic control in patients with type II diabetes who are not optimally controlled on sulfonylurea.
Ghazzi, M
RadkeMitchell, L
Venable, T
Whitcomb, R
DIABETES, 1997, 46 : 169 - 169
[35] Tofogliflozin, a Novel and Selective SGLT2 Inhibitor Improves Glycemic Control and Lowers Body Weight in Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Stable Metformin or Diet and Exercise Alone
Kadowaki, Takashi
Ikeda, Sachiya
Takano, Yasuki
Cynshi, Osamu
Christ, Andreas D.
Boerlin, Viktor
Beyer, Ulrich
Beck, Andreas
DIABETES, 2012, 61 : A22 - A22
[36] Effect of Dapagliflozin in Patients with inadequately controlled Type 2 Diabetes with Metformin
Pavlicek, V.
DIABETOLOGE, 2011, 7 (01): : 37 - 38
[37] THE COST-EFFECTIVENESS OF CANAGLIFLOZIN COMPARED WITH LIRAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED WITH METFORMIN AND SULFONYLUREA IN FRANCE
Troelsgaard, A.
Pitcher, A.
Granados, D.
Hemels, M.
Lloyd, A.
VALUE IN HEALTH, 2014, 17 (07) : A346 - A347
[38] Rosiglitazone improves glycemic control in Chinese patients with type 2 diabetes mellitus in combination with sulfonylurea
Zhu, XX
Pan, CG
Li, GW
Shi, HG
Tian, H
Yang, WY
Xing, XY
Jiang, J
Davies, C
Beck, S
Rut, A
Matfin, G
DIABETES, 2001, 50 : A135 - A135
[39] Addition of once-daily extended-release metformin to sulfonylurea significantly improves glycemic control in patients with type 2 diabetes
Schwartz, Sherwyn
Berner, Bret
Cramer, Marilou
Chiang, Yu-Kun
Lewin, Andrew
DIABETES, 2006, 55 : A463 - A463
[40] Linagliptin is Efficacious and Well Tolerated in Asian Patients With Inadequately Controlled Type 2 Diabetes
Zeng, Zhengpei
Choi, Dong Seop
Mohan, Viswanathan
Emser, Angela
Siddiqui, Kamran
Gong, Yan
Patel, Sanjay
Woerle, Hans-Juergen
DIABETES, 2012, 61 : A300 - A300

← 1 2 3 4 5 →